BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND CBL, RNF55, 867, ENSG00000110395, C-CBL, CBL2 AND Prognosis
15 results:

  • 1. Genomic Landscape of Mixed-Phenotype Acute Leukemia.
    Hennawi M; Pakasticali N; Tashkandi H; Hussaini M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232559
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The characteristics and clinical prognosis analysis of ASXL1 mutations in Chinese adult patients with primary cytogenetically normal acute myeloid leukemia by next-generation sequencing.
    Xu J; Hao Z; Chen X; Hong M; Muyey DM; Chen X; Wang H
    Leuk Lymphoma; 2022 Oct; 63(10):2321-2329. PubMed ID: 35652795
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. High Frequency of ASXL1 and IDH Mutations in Young Acute Myeloid Leukemia Egyptian Patients.
    El Nahass YH; Nader HA; Sabet S; Nooh HA; Bassiony H; Kamel M; Samra MA; Mahmoud HK; El Metnawy WH; El Refaey FA
    Asian Pac J Cancer Prev; 2022 Mar; 23(3):977-984. PubMed ID: 35345371
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. cbl mutations drive PI3K/AKT signaling via increased interaction with LYN and PIK3R1.
    Belizaire R; Koochaki SHJ; Udeshi ND; Vedder A; Sun L; Svinkina T; Hartigan C; McConkey M; Kovalcik V; Bizuayehu A; Stanclift C; Schenone M; Carr SA; Padron E; Ebert BL
    Blood; 2021 Apr; 137(16):2209-2220. PubMed ID: 33512474
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Suppressed expression of cbl-b by NF-κB mediates icotinib resistance in EGFR-mutant non-small-cell lung cancer.
    Zhang T; Zheng C; Hou K; Wang J; Zhang Y; Fan Y; Zhao H; Qu X; Liu Y; Kang J; Che X; Hu X
    Cell Biol Int; 2019 Feb; 43(2):98-107. PubMed ID: 29972257
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Adults with germline cbl mutation complicated with juvenile myelomonocytic leukemia at infancy.
    Muraoka M; Okuma C; Kanamitsu K; Ishida H; Kanazawa Y; Washio K; Seki M; Kato M; Takita J; Sato Y; Ogawa S; Tsukahara H; Oda M; Shimada A
    J Hum Genet; 2016 Jun; 61(6):523-6. PubMed ID: 26911351
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Single Nucleotide Polymorphisms in cblB, a Regulator of T-Cell Response, Predict Radiation Pneumonitis and Outcomes After Definitive Radiotherapy for Non-Small-Cell Lung Cancer.
    Li P; Wang X; Liu Z; Liu H; Xu T; Wang H; Gomez DR; Nguyen QN; Wang LE; Teng Y; Song Y; Komaki R; Welsh JW; Wei Q; Liao Z
    Clin Lung Cancer; 2016 Jul; 17(4):253-262.e5. PubMed ID: 26732495
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Peritumoral cbl is a strong independent prognostic marker after curative resection of hepatocellular carcinoma.
    Zhang JB; Zhang B; Guo L; Lin ZH; Li XQ; Guo K; Sun HC; Ye QH
    Oncotarget; 2015 Nov; 6(37):40223-34. PubMed ID: 26474280
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The E3 ubiquitin ligase cbl-b improves the prognosis of RANK positive breast cancer patients by inhibiting RANKL-induced cell migration and metastasis.
    Zhang L; Teng Y; Fan Y; Wang Y; Li W; Shi J; Ma Y; Li C; Shi X; Qu X; Liu Y
    Oncotarget; 2015 Sep; 6(26):22918-33. PubMed ID: 26087197
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Predicting the outcome of Sjogren's syndrome-associated non-hodgkin's lymphoma patients.
    Papageorgiou A; Ziogas DC; Mavragani CP; Zintzaras E; Tzioufas AG; Moutsopoulos HM; Voulgarelis M
    PLoS One; 2015; 10(2):e0116189. PubMed ID: 25723713
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type.
    Ito Y; Kimura H; Maeda Y; Hashimoto C; Ishida F; Izutsu K; Fukushima N; Isobe Y; Takizawa J; Hasegawa Y; Kobayashi H; Okamura S; Kobayashi H; Yamaguchi M; Suzumiya J; Hyo R; Nakamura S; Kawa K; Oshimi K; Suzuki R
    Clin Cancer Res; 2012 Aug; 18(15):4183-90. PubMed ID: 22675173
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Expressions of c-cbl, cbl-b and EGFR and its role of prognosis in NSCLC].
    Jiao X; Jin B; Qu X; Yan S; Hou K; Liu Y; Hu X
    Zhongguo Fei Ai Za Zhi; 2011 Jun; 14(6):512-7. PubMed ID: 21645455
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Cost utility in the United States of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone for the treatment of elderly patients with diffuse large B-cell lymphoma.
    Hornberger JC; Best JH
    Cancer; 2005 Apr; 103(8):1644-51. PubMed ID: 15756658
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Low-grade non-Hodgkin's lymphomas. Study of 73 cases].
    Coma A; Jonte F; Zanabili Y; Soto I; Fanjul F; Carrera D; Rayón C; Luño E; Jalón S; Pinto V
    Sangre (Barc); 1992 Aug; 37(4):249-54. PubMed ID: 1514137
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [T-cell lymphoma of the skin--clinicopathological relationships, therapy and survival].
    Nagatani T; Kin S; Baba N; Miyamoto H; Nakajima H
    Nihon Hifuka Gakkai Zasshi; 1989 Apr; 99(5):579-91. PubMed ID: 2585773
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.